Filing Details
- Accession Number:
- 0001209191-16-115916
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-27 16:19:37
- Reporting Period:
- 2016-04-25
- Filing Date:
- 2016-04-27
- Accepted Time:
- 2016-04-27 16:19:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
913165 | Exactech Inc | EXAC | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 592603930 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1206762 | J Gary Miller | 531 Sw 26Th Place Gainesville FL 32601 | Executive Vice President, R&D | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2016-04-25 | 4,725 | $23.14 | 190,720 | No | 4 | S | Indirect | by Partnership |
Common Stock | Disposition | 2016-04-26 | 3,260 | $23.06 | 187,460 | No | 4 | S | Indirect | by Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | by Partnership |
No | 4 | S | Indirect | by Partnership |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 30,914 | Direct |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock | Non-Qualified Option (right to buy) | $14.27 | 2011-12-18 | 2016-12-18 | 5,000 | 5,000 | Direct |
Common Stock | Non-Qualified Option (right to buy) | $18.95 | 2014-02-28 | 2017-02-28 | 2,800 | 2,800 | Direct |
Common Stock | Incentive Stock Option (right to buy) | $16.33 | 2017-02-22 | 2019-02-22 | 19,800 | 19,800 | Direct |
Common Stock | Incentive/Non-Qualified Option (right to buy) | $18.55 | 2018-02-25 | 2020-02-25 | 16,000 | 16,000 | Direct |
Common Stock | Non-Qualified Stock Option (right to buy) | $20.90 | 2019-05-09 | 2021-05-09 | 12,000 | 12,000 | Direct |
Common Stock | Non-Qualified Stock Option (right to buy) | $23.28 | 2020-04-29 | 2022-04-29 | 9,000 | 9,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2016-12-18 | 5,000 | 5,000 | Direct |
2017-02-28 | 2,800 | 2,800 | Direct |
2019-02-22 | 19,800 | 19,800 | Direct |
2020-02-25 | 16,000 | 16,000 | Direct |
2021-05-09 | 12,000 | 12,000 | Direct |
2022-04-29 | 9,000 | 9,000 | Direct |
Footnotes
- Such shares were sold pursuant to a Rule 10b5-1 plan to sell a maximum of 50,000 shares of common stock beginning January 4, 2016 and expiring December 30, 2016.
- Such options are currently exercisable as regards 15,840 of the covered shares. The remaining options are exercisable, as regards 3,960 of the covered shares, on the fifth anniversary of the date of grant.
- Such options are currently exercisable as regards 9,600 of the covered shares. The remaining options are exercisable, as regards 3,200 of the covered shares on the fourth anniversary of the date of grant, and as regards 3,200 of the covered shares, on the fifth anniversary of the date of grant.
- Such options are currently exercisable as regards 2,400 of the covered shares. The remaining options are exercisable, as regards 2,400 of the covered shares, on the second anniversary of the date of grant, as regards 2,400 of the covered shares, on the third anniversary of the date of grant, as regards 2,400 of the covered shares on the fourth anniversary of the date of grant, and as regards 2,400 of the covered shares, on the fifth anniversary of the date of grant.
- Such options are exercisable as regards 1,800 of the covered shares, on the first anniversary of the date of grant, as regards 1,800 of the covered shares, on the second anniversary of the date of grant, as regards 1,800 of the covered shares, on the third anniversary of the date of grant, as regards 1,800 of the covered shares on the fourth anniversary of the date of grant, and as regards 1,800 of the covered shares, on the fifth anniversary of the date of grant.